No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
LIXT Lixte Biotechnology
- 3.2600
- +0.0400+1.24%
Close Apr 26 16:00 ET
- 3.3500
- +0.0900+2.76%
Post 16:55 ET
7.33MMarket Cap-1225P/E (TTM)
3.3250High3.1931Low4.16KVolume3.3250Open3.2200Pre Close13.60KTurnover0.21%Turnover RatioLossP/E (Static)2.25MShares9.500052wk High14.82P/B6.44MFloat Cap1.580052wk Low--Dividend TTM1.98MShs Float71.9000Historical High--Div YieldTTM4.10%Amplitude1.5800Historical Low3.2670Avg Price1Lot Size
Full Hours
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Express News | Lixte Biotechnology Holdings Files $50M Offering
Express News | Lixte Biotechnology Holdings Inc Files for Mixed Shelf Offering of up to $50 Mln- SEC Filing
Express News | Watching Lixte Biotechnology; White Diamond Research Posts On X "BREAKING NEWS: Lixte Biotechnology Lied: Its Publication Yesterday Isn't New – It's The Same One They Published Over A Year Ago"
Sector Update: Health Care Stocks Advance Late Afternoon
Health care stocks were rising late Wednesday afternoon, with the NYSE Health Care Index adding 0.8% and the Health Care Select Sector SPDR Fund (XLV) climbing 1%. The iShares Biotechnology ETF (IBB)
Top Midday Gainers
iBio's (IBIO) shares were up 211% amid heavy trading Wednesday, a day after the company said it signed a securities purchase agreement for a private investment in public equity financing with expected
SMR, GCTS and GSIW Among Mid-day Movers
Comments
$Lixte Biotechnology(LIXT.US$ this will hit 4.15 by eod....
1
$Lixte Biotechnology(LIXT.US$
How big is the GVHD market?
US$ 2.71 billion
The Graft Versus Host Disease (GVHD) Treatment Market in 2023 is US$ 2.71 billion, and is expected to reach US$ 5.17 billion by 2031 at a CAGR of 8.42%. FutureWise Research published a report that analyzes Graft Versus Host Disease (GVHD) Treatment Market trends to predict the market's growth.Feb 6, 2024
How big is the GVHD market?
US$ 2.71 billion
The Graft Versus Host Disease (GVHD) Treatment Market in 2023 is US$ 2.71 billion, and is expected to reach US$ 5.17 billion by 2031 at a CAGR of 8.42%. FutureWise Research published a report that analyzes Graft Versus Host Disease (GVHD) Treatment Market trends to predict the market's growth.Feb 6, 2024
$Lixte Biotechnology(LIXT.US$ loaded 👀✔️
10
3
10
1
14
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg